latest update:
[RxAtlas]

drug summary · 3 NDC codes

ADVAIR HFA 230 ug/1; 21 ug/1

fluticasone propionate and salmeterol xinafoate

HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status NDA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.

dataset id 97811NDC codes 3application NDA021254RxCUI —

Facts

Field definitions, types, and provenance rules are in the data dictionary.

generic namefluticasone propionate and salmeterol xinafoate
active ingredientsFLUTICASONE PROPIONATE, SALMETEROL XINAFOATE
dosage formAEROSOL, METERED
routeRESPIRATORY (INHALATION)
strength230 ug/1; 21 ug/1
marketing statusNDA
DEA schedulenot reported
application numberNDA021254
ATC codenot reported
RxCUInot reported
manufacturerGlaxoSmithKline LLC
product typeHUMAN PRESCRIPTION DRUG
pharmacologic classAdrenergic beta2-Agonists [MoA]; Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; beta2-Adrenergic Agonist [EPC]

NDC codes

3 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.

NDCPackage description
00173071720—
00173071722—
0173-0717—

Other fluticasone propionate and salmeterol xinafoate products

2 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.

Work with this record

  • Field definitions

    Types, scope, and provenance rules for every exported field.

  • REST API

    Query the same gate-backed records programmatically.

  • Evaluation sample

    Download a bounded slice before buying.

  • $29 API Pass

    Seven days of REST and MCP access to the full catalogue; credited toward the licence.